Among breast cancer circulating tumor cells, CD44+CD24+ALDH1+ subpopulation show an increased tumorigenic potential, while EpCAM+CD44+CD47+MET+ subset denotes cells with high metastatic ability (66). Here, CD44 is linked to neoplasm.